Genetic testing should be offered to more individuals with suspected inherited cancer risk, but it also needs to be managed in an effective and efficient way.

Our program streamlines this entire process so the focus can be on helping patients and providing accurate results, not time-consuming paperwork and communications logistics. Manage patient information between healthcare providers, clinics and genetic counselors in an all-in-one efficient platform.

• Purposefully designed to be as turnkey as you decide;
• Provides personalized cancer risk information;
• Facilitates recommendations for additional screening;
• Identifies at-risk family members;
• Integrates seamlessly into your workflow;
• Helps reduce missed patients across clinics and providers.

$0

Due to Ambry’s extensive contracts with commercial payers (covering 95% of insured lives), testing is affordable and accessible for the majority of patients. Four out of five patients pay $0 and for those who do pay, they pay on average less than $100. Both patients and providers are notified in advance of any out-of-pocket costs. Which patients will receive genetic testing?

A patient’s personal and family history of cancer will be evaluated to determine if they are eligible for hereditary cancer genetic testing. Our program uses National Comprehensive Cancer Network (NCCN) genetic testing criteria, which outline various factors that may indicate a need for genetic testing, such as type of cancer, age of diagnosis, and number of family members with cancer. Any patient who meets these criteria will be offered genetic testing.